Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Prev Med. 2020 Feb 20;134:106034. doi: 10.1016/j.ypmed.2020.106034

Table 3.

Mediation Effect of Lifetime Externalizing and Internalizing Symptoms on the Association between ACEs and Prescription Opioid Misuse: National Epidemiological Survey on Alcohol and Related Conditions, 2012–2013

Outcome Variable Total Effect Natural Indirect Effect Proportion Mediated
AOR or β (95% CI) AOR or β (95% CI)
Mediator: internalizing symptoms
 Past-year opioid misuse 1.06 (1.03, 1.09) 1.03 (1.02, 1.03) 47%
 Lifetime opioid misuse 1.07 (1.05, 1.09) 1.02 (1.02, 1.03) 34%
 Early onset of opioid misuse 1.09 (1.05, 1.12) 1.02 (1.01, 1.03) 22%
 Past-year OUD 1.11 (1.06, 1.17) 1.06 (1.05, 1.08) 58%
 Lifetime OUD 1.12 (1.08, 1.17) 1.06 (1.05, 1.07) 50%
 Frequency of opioid misusea 0.02 (0.01, 0.03) 0.01 (0.008, 0.012) 49%
Mediator: externalizing symptoms
 Past-year opioid misuse 1.06 (1.04, 1.09) 1.03 (1.02, 1.04) 50%
 Lifetime opioid misuse 1.08 (1.06, 1.10) 1.04 (1.03, 1.04) 48%
 Early onset of opioid misuse 1.12 (1.08, 1.15) 1.05 (1.04, 1.05) 43%
 Past-year OUD 1.09 (1.03, 1.14) 1.04 (1.03, 1.05) 46%
 Lifetime OUD 1.11 (1.07, 1.15) 1.04 (1.04, 1.05) 43%
 Frequency of opioid misusea 0.03 (0.02, 0.04) 0.02 (0.01, 0.02) 61%

AOR = adjusted odds ratio; CI = confidence interval.

All models were adjusted for internalizing and externalizing symptoms, sex, race/ethnicity, education, marital status, region, employment status, cannabis use, and tobacco use.

a

β coefficient was reported.